Meningococcal Disease Treatment Market, By Therapy Type (Antibiotics (Penicillin, Ampicillin, Chloramphenicol, and Ceftriaxone) and (Vaccines (Bivalent, Trivalent, and Tetravalent)), By Route of Administration (Injectable and Oral), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
Meningococcal infection is a bacterial infection caused by Neisseria meningitidis, also known as meningococcus, a gram-negative bacterium. Meningococcal meningitis is a serious infection of the thin lining that surrounds the brain and spinal cord.
Furthermore, according to the World Health Organization Meningococcal meningitis is observed worldwide but the highest burden of the disease is in the meningitis belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east. Around 30,000 cases are still reported each year from that area.
Market Dynamics
The global meningococcal disease treatment market is expected to witness significant growth during the forecast period owing to the increasing prevalence of meningococcal disease. According to the centers for disease control and prevention, there were about 330 total cases of meningococcal disease reported in the U.S. in 2018.
Key features of the study:
- This report provides in-depth analysis of the global meningococcal disease treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global meningococcal disease treatment market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are GlaxoSmithKline Plc., Novartis AG, Sanofi Pasteur Inc., Wockhardt Ltd., Kent Pharmaceuticals, Stravencon Limited., F. Hoffmann-La Roche Ltd., Athlone Laboratories, and Pfizer Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global meningococcal disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningococcal disease treatment market
- Global Meningococcal Disease Treatment Market, By Therapy Type:
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- Global Meningococcal Disease Treatment Market, By Route of Administration:
- Injectable
- Oral
- Global Meningococcal Disease Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
- Global Meningococcal Disease Treatment Market, By Region:
- North America
- By Therapy Type
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- By Route of Administration
- Injectable
- Oral
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Country
- U.S.
- Canada
- Latin America
- By Therapy Type
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- By Route of Administration
- Injectable
- Oral
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Therapy Type
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- By Route of Administration
- Injectable
- Oral
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Therapy Type
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- By Route of Administration
- Injectable
- Oral
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- Middle East
- By Therapy Type
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- By Route of Administration
- Injectable
- Oral
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Therapy Type
- Antibiotics
- Penicillin
- Ampicillin
- Chloramphenicol
- Ceftriaxone
- Vaccines
- Bivalent
- Trivalent
- Tetravalent
- By Route of Administration
- Injectable
- Oral
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GlaxoSmithKline Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Sanofi Pasteur Inc.
- Wockhardt Ltd.
- Kent Pharmaceuticals
- Stravencon Limited.
- F. Hoffmann-La Roche Ltd.
- Athlone Laboratories
- Pfizer Inc.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Impact Analysis
- PEST Analysis
- Technological Advancements
- Market Trends
- Key Developments
- New Launches and Approval
- 4. Global Meningococcal Disease Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- Research and Development
- Government Measures to combat COVID-19
- 5. Global Meningococcal Disease Treatment Market, By Therapy Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Penicillin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ampicillin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Chloramphenicol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ceftriaxone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Bivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Trivalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Tetravalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- 6. Global Meningococcal Disease Treatment Market, By Route of Administration, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- 7. Global Meningococcal Disease Treatment Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- 8. Global Meningococcal Disease Treatment Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Therapy Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Therapy Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- GlaxoSmithKline Plc. *
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi Pasteur Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Wockhardt Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Kent Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Stravencon Limited.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Athlone Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 35 market data tables and 36 figures on "Meningococcal Disease Treatment Market” - Global forecast to 2028
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook